Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

General disorders and administration site conditions – page 3

  • 140 clinical trials
  • 57 recruiting
  • 120 conditions
  • 23 countries

Conditions in this area

120 conditions with trials, the busiest first

Procedural pain29Pain21Critical illness18Medical device site joint infection8Inflammation7Still's disease6Chronic fatigue syndrome5Friedreich's ataxia5Cachexia4Device related infection4Hereditary ataxia4Hot flush4Postoperative analgesia4Anxiety2Colorectal cancer2Delirium tremens2Diabetic neuropathy2Febrile neutropenia2Hip arthroplasty2Juvenile idiopathic arthritis2Menopausal symptoms2Neuropathy peripheral2Parkinson's disease2Pyrexia2+96

Clinical trials in General disorders and administration site conditions

140 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

140 clinical trials

Critical illness

Recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Avibactam
  • Sponsor:UZ Leuven

Procedural pain+1

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Esketamine
  • Sponsor:Academisch Ziekenhuis Maastricht

Aortic valve stenosis+2

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Stichting Radboud universitair medisch centrum

Procedural pain

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tapentadol Hydrochloride
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)

Critical illness+1

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin Sulfate
  • Sponsor:Assistance Publique Hopitaux De Paris

Medical device site joint infection

Recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gallium Citrate Ga-68
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Critical illness

Recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Furosemide
  • Sponsor:Region Hovedstaden

Cardiac arrest+4

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Potassium Chloride
  • Sponsor:Hopital Erasme

Pain+1

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Buprenorphine
  • Sponsor:Stichting Radboud universitair medisch centrum

Critical illness

Recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Ziekenhuis Gent

Decreased appetite

Recruiting
Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Artelo Biosciences Limited

Hereditary ataxia+1

Recruiting
InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Vo659
  • Sponsor:Vico Therapeutics B.V.

Substances studied in this area

The therapies tested most often in General disorders and administration site conditions trials.

Sodium Chloride18 clinical trialsParacetamol10 clinical trialsIbuprofen5 clinical trialsLidocaine Hydrochloride5 clinical trialsPlacebo5 clinical trialsRifampicin5 clinical trialsLidocaine Hydrochloride Monohydrate4 clinical trialsLinezolid4 clinical trialsPiperacillin4 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.